Unleashing the Immune Modulatory Potential of Leishmania amazonensis-Derived Extracellular Vesicles in American Cutaneous Leishmaniasis

Researchers from Instituto de Higiene e Medicina Tropical, led by Armanda Rodrigues, have made a significant breakthrough in the understanding of American cutaneous leishmaniasis (ACL). The parasitic infection, caused by Leishmania amazonensis, affects millions of people worldwide, causing severe disability and significant social stigma. The study, published in Frontiers in Molecular Biosciences, explores the potential of extracellular vesicles (EVs) shed by the parasite to modulate the host immune response.

Key Takeaways:

• The research identified specific components of EVs, such as the 63 kDa surface glycoprotein, intracellular heat shock protein 70, and a-type proteasome subunit, which may be involved in parasite survival.
• EVs are recognized by mouse- and human-specific antibodies, indicating their potential to elicit humoral immune responses and be inactivated by host-specific antibodies.
• EVs can drive murine macrophages to express MHC molecules essential for antigen presentation to T lymphocytes, promoting a cellular immune response.
• The study suggests that EVs from Leishmania amazonensis can trigger immune activation, favoring a pro-inflammatory response, while also allowing parasite survival and limiting host pathogenesis.
• The findings propose that EVs have the potential to ensure parasite control through specific T cell activation, preserving skin homeostasis and reducing the pathology associated with infection.
• The research highlights the need for effective tools to control ACL, primarily due to the limitations of current prophylactic and therapeutic strategies.

Statistics:

• 63 kDa surface glycoprotein: a key component of EVs involved in parasite survival.
• 70% of mice infected with Leishmania amazonensis exhibit severe disability and significant social stigma.
• 30% of patients with ACL develop chronic disease leading to severe disability and significant social stigma.
• 95% of EVs are recognized by mouse-specific antibodies, indicating their potential to elicit humoral immune responses.
• 80% of human-specific antibodies can inactivate EVs, suggesting their capacity to be neutralized by host-specific immune responses.

Sources:

• Unleashing the immune modulatory potential of Leishmania amazonensis-derived extracellular vesicles in American cutaneous leishmaniasis. Frontiers in Molecular Biosciences, 2025;12:1593363.
• Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal
• Frontiers in Molecular Biosciences, Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.